UBS
UBS Group AG
$48.77-3.75%
Setup
Near pivot
Buy Zone
$51.03-$53.58
Sector
Banks - Diversified
Industry
Banks - Diversified
38
Recommendation
Avoid
Avoid
Too many CANSLIM criteria failing.
UBS chart
Loading chart…
ADX
Developing26.1Long Term
Up ↑Intermediate Term
Up ↑Short Term
Up ↑Overall Quality38
RS Rating
71
relative strength
Fundamentals
44
Weak fund-Q
Volume Demand
68
+104% vs avg
Technical Setup
50
4/8 checks
Industry/Theme
91
Banks - Diversified
Trade Plan
Avoid
Entry
$51.03
Entry Zone
$51.03-$53.58
Stop / Risk
$46.95
RS Rating
71
Volume confirmed
No
Targets
$61.24 / $63.79
Breakout · IBD Setup
2 ✓ 6 ✗
Entry $51.03–$53.58Stop $46.95Target $61.24 / $63.79
Market regimeRange
Quality38
RS Rating71
Above 50-MA-2.12%
Above 200-MA+3.88%
VolumeWeak
In Buy ZoneNo
Not extendedOK
Invalidation · Close below stop
How this came together
38
MarketRange
SetupNear pivot
ConfidenceExperimental · not backtested
Fund-Q44 · Weak
StatusAvoid
Stock Data
52-Week Range36 – 56
Price % Chg YTD6.67%
Price % Chg 4wk2.85%
50-Day Avg Vol1.9 Mil
P/E Ratio15.7
Market Cap$145B
SectorFinancial
IndustryBanks - Diversified
Company Fundamentals
EPS % Chg (Qtr)11.68%
Sales % Chg (Qtr)0.5%
EPS Growth 5y6.13%
Sales Growth 5y19.62%
Annual ROE10.9%
Gross Margin—
Operating Margin16.27%
Net Margin12.07%
Debt / Equity4.18
Setup levels
Current price
$48.77
Pivot
$51.03
Distance to buy
-12.9%
52-week range
35.83-55.99
Trigger evidence
No active trigger evidence available.
Pattern levels: pivot 51.03
Financial health checks
3/5
Return on equity above 15%
ROE 10.9%
Net margin above 10%
Net margin 12.07%
EPS growing quarter on quarter
EPS q/q 11.68%
Sales growing quarter on quarter
Sales q/q 0.5%
Debt to equity below 1.0
D/E 4.18
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE10.9%
vs sector -4.4%
Net margin12.07%
vs sector -8.1%
Gross margin—
EPS growth q/q11.68%
vs sector -5.5%
Sales growth q/q0.5%
vs sector -6.1%
Debt / equity4.18
vs sector +1.43
Business quality
44
GradeWeak
EPS rating40
P/E15.7
Market cap$145B
IndustryBanks - Diversified
Technical checks
Über 50-MA
Fail
Über 200-MA
Pass
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Fail
Nicht überextended
Pass
Über 21-EMA
Pass
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-11-01
Trigger date
—
Days on list
5
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.